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A C3(H20) recycling pathway is a component
of the intracellular complement system
Michelle Elvington,1 M. Kathryn Liszewski,1 Paula Bertram,1 Hrishikesh S. Kulkarni,2 and John P. Atkinson1
Division of Rheumatology, and 2Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine (WUSM), St. Louis, Missouri, USA.

1

An intracellular complement system (ICS) has recently been described in immune and nonimmune human cells. This system
can be activated in a convertase-independent manner from intracellular stores of the complement component C3. The source
of these stores has not been rigorously investigated. In the present study, Western blotting identified a band corresponding
to C3 in freshly isolated human peripheral blood cells that was absent in corresponding cell lines. One difference between
native cells and cell lines was the time absent from a fluid-phase complement source; therefore, we hypothesized that loading
C3 from plasma was a route of establishing intracellular C3 stores. We found that many types of human cells specifically
internalized C3(H2O), the hydrolytic product of C3, and not native C3, from the extracellular milieu. Uptake was rapid,
saturable, and sensitive to competition with unlabeled C3(H2O), indicating a specific mechanism of loading. Under steadystate conditions, approximately 80% of incorporated C3(H2O) was returned to the extracellular space. These studies identify
an ICS recycling pathway for C3(H2O). The loaded C3(H2O) represents a source of C3a, and its uptake altered the cytokine
profile of activated CD4+ T cells. Importantly, these results indicate that the impact of soluble plasma factors should be
considered when performing in vitro studies assessing cellular immune function.

Introduction

The complement system’s component C3 is the most abundant
complement protein in blood and the central player in all three
activation pathways (classical, alternative, and lectin). Complement engagement resulting in C3 cleavage to its biologically active
fragments C3a (an inflammatory mediator) and C3b (an opsonin)
is essential to innate immune protection from bacterial infections
(1–3). C3 activation is traditionally thought to occur exclusively in
the extracellular space.
Until the past few years, intracellular C3 activation was not
considered. Several recent reports, however, have indicated a
role for intracellular C3 in mediating key events for host defense
and cell survival. Our group has described the presence of C3
stores and intracellular C3 activation in human CD4+ T cells (4).
In that study, C3a and C3b were generated from an intracellular
C3 source, leading to cellular consequences, including cell activation and lineage development. Importantly, a correlation between
hyperactive intracellular C3a generation and IFN-γ production by
CD4+ T cells from autoimmune arthritis patients was demonstrated, indicating that dysregulated intracellular C3 activation is likely
to play an important role in disease. Additionally, a role for intracellular C3 has been highlighted recently in the literature through
studies demonstrating that internalization of C3b-opsonized
pathogens or cells can direct a proinflammatory immune response
upon entering the intracellular milieu (5, 6). Apoptotic cells have
been shown to internalize factor H (FH), which regulated endogenous intracellular C3 activation, resulting in enhanced apoptotic
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cell–surface opsonization. Also, the internalized FH complexed
with nucleosomes and enhanced their clearance by phagocytes,
thereby limiting inflammation (7).
The generation of C3a and C3b by human CD4+ T cells (8)
is essential for the development of Th1 cell–mediated responses
through autocrine stimulation of the C3aR and the complement
membrane regulator CD46, respectively (9, 10). To further define
the mechanism governing C3a and C3b generation by CD4+ T cells,
Liszewski et al. (4) demonstrated that activation occurs inside the
CD4+ T cell and that the processing into C3a and C3b is convertase
independent, but cathepsin L (CTSL) dependent. Further, CTSLdriven C3a generation is required for CD4+ T cell survival, and
shuttling of C3a to the cell surface is necessary for Th1 effector
cell differentiation and proinflammatory cytokine production (4).
In a follow-up to this study, the Kemper group demonstrated that
intracellular C3b generation (and autocrine CD46 stimulation) is
required for metabolic reprogramming that allows Th1 cell activation and contraction (11). Further, this group suggested that such
reprogramming also provides for a novel “complement-metabolism-inflammasome” axis (12). Together, these studies establish
an important role for intracellular C3 activation in normal CD4+ T
cell immune function. Moreover, intracellular C3 stores are present in many other cell types, suggesting this phenomenon may be
of broad physiologic significance (4).
Despite growing evidence indicating the importance of intracellular C3 stores in human T cell homeostasis (4, 8, 11, 12), the
source and composition of these stores have not been rigorously
investigated. Initially, we set out to characterize the composition
of the intracellular C3 stores. Unexpectedly, we recognized a difference in the C3 species present in peripheral blood cells (PBCs)
compared with cell lines by Western blotting (WB). Since a major
distinction between cell lines and native cells is the time away
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Figure 1. Human cell lines demonstrate uptake of C3 from an exogenous source. (A) Whole
cell lysates from peripheral blood B lymphocytes (B cell) and a human B cell line (Farage)
were prepared and analyzed for C3 under reducing (R) and nonreducing (NR) conditions
by WB. Lane 5 is a 4-fold longer exposure of lane 3. C3, 30 ng; C3b, 30 ng; B cells, 7.4 × 104
cell equivalents; Farage, 6.3 × 105 cell equivalents. (B) Two human cells lines, ARPE-19 and
Farage, were incubated in 10% NHS for 30 minutes to assess whether they take up C3. C3,
30 ng; cell lysates, 2.4 × 105 cell equivalents. (C) Farage cells were incubated for 15 minutes
with commercially available purified C3 and washed 3 (lane 3), 6 (lane 4), or 9 (lane 5) times
prior to preparation of cell lysates. Cell lysates (top panel), final wash supernatants (bottom
panel). C3, 30 ng; cell lysates, 2.4 × 105 cell equivalents; wash supernatants, 20 μl (of 100 μl).
Representative blot of 4 (A and B) or 2 (C) independent experiments.

from a source of human C3, we hypothesized that cells may “load”
C3 from the surrounding milieu.
In the current study, we demonstrate that one route of establishing intracellular C3 stores is uptake from the extracellular space
via plasma. We characterize the C3 uptake process and show that
this is a generalized phenomenon, not being limited to a specific
or few cell types. Interestingly, we establish that cells specifically
load C3(H2O), not native C3. In a process known as tickover, a small
amount of C3 continuously activates in the fluid phase by hydrolysis of the internal thioester bond. If it does not covalently bind to a
target within microseconds, C3(H2O) is formed (13). Here, we show
that, following uptake, a majority of C3(H2O) loaded is returned to
the cell exterior. Additionally, the C3(H2O) remaining provides an
intracellular source of C3a. These results point to a C3(H2O) recycling pathway being a major player in the intracellular complement
system (ICS) that operates continuously in vivo.

Results

Human cell lines load C3 from an exogenous source. In experiments
designed to further characterize the intracellular C3 stores identified in a previous publication (4), we observed by WB that human
peripheral blood B lymphocytes (B cell) (Figure 1A) contained
native-like C3. In contrast, Farage, a cell line derived from a
human B cell lymphoma (Figure 1A), lacked detectable native-like
C3 by WB (Figure 1A). This was not pro-C3, a single chain predominantly pre-Golgi form that can be detected in cells secreting C3,

because under reducing conditions, the C3 α and β chains (Figure
1A) were generated (14). This distinction between PBCs and their
respective cell lines was not limited to B cells, but was true for
several other PBCs tested, including CD4+ T cells versus Jurkat, a
human T lymphocyte cell line (not shown). Therefore, PBCs contain stores of native-like C3 that were not detected in cultured cell
lines of related cell types by WB.
A major difference between PBCs and cultured cells is that the
latter have not been exposed to a source of human C3 for many
generations. We therefore hypothesized that PBCs may load C3
from blood and/or synthesize and store C3. Consequently, Farage and ARPE-19, a human retinal epithelial cell line, were incubated with 10% normal human serum (NHS) and assessed for C3
by WB. As expected, Farage and ARPE-19 cell lines grown under
standard culture conditions did not contain a detectable nativelike C3 band at 190 kDa (Figure 1B). However, consistent with our
“loading” hypothesis, after a short exposure to 10% NHS, Farage
and ARPE-19 cells demonstrated a band corresponding to C3 (Figure 1B), identical in Mr to C3 observed in primary B lymphocytes
(see Figure 1A). The same results were observed whether these
cell lines were exposed to plasma or whole blood (Supplemental
Figure 1A; supplemental material available online with this article;
https://doi.org/10.1172/JCI89412DS1).
To further assess whether C3 loads into cells, we incubated
Farage cells with commercially available purified human C3.
Similar to the results obtained with NHS, incubation with purijci.org   Volume 127   Number 3   March 2017
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tory. We detected minimal or no
uptake of “fresh” C3 by Farage
cells (Figure 2A). To further support the hypothesis that C3(H2O),
but not native C3, is taken up,
we compared the uptake efficiency of commercially available C3 versus C3 inactivated
by treatment with methylamine
C3(H2O] analog, C3[MA] ref. 16).
After incubation with 5 μg/ml of
either C3 or C3(MA), Farage cells
loaded approximately 10× more
C3(MA) compared with C3, indicating that cells were loading the
thioester-inactivated fraction of
the C3 (Figure 2B). Since a fraction of the commercially available C3 is of the form C3(H2O),
we used a lower concentration of
C3 and C3(MA), as shown in Figure 2B, to ensure we would not
reach saturation of loading with
the C3 due to its percentage as
Figure 2. Loading of C3(H2O) is specific. Uptake of C3(H2O) versus native C3 was investigated by incubating
C3(H2O). This would result in an
Farage cells with (A) 20 μg/ml of a commercially available C3 preparation (C3) or a freshly purified C3 preparainability to detect a difference in
tion (fresh C3) or (B) 5 μg/ml commercially available C3 or C3(MA). Cell lysates were prepared and analyzed for
uptake compared with C3(MA).
uptake by WB. GAPDH, loading control. C3, 20 ng (lane 1); cell lysates, 2.4 × 105 cell equivalents. (C) Labeled C3
(C3-DL488) was utilized to visualize C3 loading into cells and determine whether uptake is sensitive to competi- These data support the conclusion that C3(H2O), not native C3,
tion with unlabeled protein. ARPE-19 cells were loaded for 5 minutes without (top panel) or with (bottom panel,
10-fold) 2-, 5-, or 10-fold excess concentrations of unlabeled C3(H2O) followed by C3-DL488 (50 μg/ml) for
is preferentially loaded into cells.
an additional 15 minutes and visualized by confocal microscopy. Original magnification, ×60. C3-DL488
There is a dramatic conformauptake per cell is quantified in part D. n = 3 representative cells per condition. Blue, DAPI; green, C3-DL488.
tional change upon tickover of
*P < 0.05 compared with no excess of unlabeled C3(H2O) by 1-way ANOVA with Dunn’s multiple comparison
C3 to C3(H2O) (17–19). Thus, and
test. (E) To determine whether denatured C3(MA) is internalized, Farage cells were incubated with 10 μg/ml
importantly, this points to uptake
C3(MA) or heat-denatured C3(MA) (hD-C3[MA]). C3, 30 ng (lane 1); cell lysates, 4 × 105 cell equivalents (lanes
3–5). (A, B, and E) Blots are representative of 2 independent experiments.
being mediated by a mechanism
that specifically recognizes the
conformation of C3(H2O).
To further characterize the specificity of C3(H2O) uptake,
fied C3 demonstrated a C3-like band (Figure 1C). To check that
the C3 detected is not secondary to carryover, we washed Farage
intracellular C3(H2O) loading by Farage and ARPE-19 cells was
cells 3, 6, or 9 times prior to preparing the lysates. The C3 did not
visualized by incubating cells with Dylight 488–conjugated C3
dilute out of the lysates, even after it was undetectable in the wash
(C3-DL488) and analyzed by confocal microscopy (Figure 3A).
supernatants (Figure 1C). Note that, as shown in Figure 1C, we
Following labeling of purified C3, C3-DL488, like C3(H2O), does
employed a polyclonal Ab to C3a, which gives the same results as
not contain an intact thioester bond, as assessed by autolytic
the goat anti-C3 pAb, i.e., the C3 in the cells contains C3a and this
cleavage (Supplemental Figure 1B). ARPE-19 cells rapidly loaded
further establishes that it is native C3 and/or C3(H2O).
the C3-DL488, and the uptake could be specifically inhibited in a
dose-dependent manner by the addition of increasing concentraCells specifically take up C3(H2O), not native C3. In a review of the
tions of unlabeled C3(H2O) to the culture media (Figure 2, C and
literature, we located one report describing intracellular uptake of
C3 by the α2-macroglobulin receptor (α2MR) (15). In that article, the
D). We then heat denatured C3(H2O), which abrogated loading,
α2MR was reported to specifically mediate uptake of C3(H2O). Under
pointing out that C3(H2O) uptake requires its 3D structure (Figure
physiologic conditions, C3 turns over in blood at about 1% to 2% per
2E). We next showed that loading has species specificity in that
hour to generate C3 with a cleaved thioester bond (13). Almost all
human cell lines incubated with normal mouse serum did not take
of this transiently active C3 does not become bound to a target and
up mouse C3 (Supplemental Figure 1C). Taken with the preceding
therefore is inactivated by combining with H2O (C3[H2O]).
data demonstrating specificity of uptake for C3(H2O) compared
To determine whether C3(H2O) was the form being internalwith native C3, these results strongly suggest that C3(H2O) interized in our experiments, we compared uptake of commercially
nalization occurs via a specific recognition system.
available C3 that has undergone several freeze/thaw cycles (genIntracellular location of C3(H2O). One common mechanism for
erates more C3[H2O]) to that of C3 freshly prepared in our laborainternalization of a ligand is clathrin-coated pit–mediated endocy972
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Figure 3. C3 is localized to intracellular compartments following rapid uptake. (A) Representative confocal microscopy images showing that exogenously
added C3 colocalizes to early endosomes. ARPE-19 cells were incubated with C3-DL488 (50 μg/ml, green) for 5 minutes, washed, and then incubated for
an additional 1, 15, or 60 minutes in normal growth media. C3-DL488–loaded cells were washed, fixed, and permeabilized at the indicated time points
and then stained for early endosomes (Rab5, red). Blue, DAPI. Representative images are from 3 independent experiments. Original magnification, ×60.
(B) C3 is predominately intracellular in freshly isolated CD4+ T cells by flow cytometry. Ab, goat anti-C3. Gray and black histograms, isotype controls; red
histogram, extracellular; blue histogram, intracellular. Representative of 5 independent experiments.

tosis. This results in localization of the cargo into early endosomes.
To follow the path of internalized C3(H2O), we performed a kinetic evaluation of loading in ARPE-19 cells (Figure 3A) and CD4+ T
cells (Supplemental Figure 2), utilizing C3-DL488, a marker for
early endosomes (Rab5), and confocal microscopy. Immediately
following exposure to C3-DL488 (<1 minute), the majority of the
C3 was detected in a pattern suggesting association with the plasma membrane. Within 15 minutes after loading, the C3-DL488
colocalized to early endosomes, characteristic of clathrin-coated
pit–mediated endocytosis. An hour after loading of C3-DL488, it
no longer colocalized with Rab5 and a portion of the C3-DL488
was lost, consistent with our subsequent results demonstrating
recycling of the loaded C3(H2O) (see Figure 5G).
To augment the observation that C3(H2O) was internalized,
we performed colocalization studies with surface marker CD46
at 15 minutes after C3(H2O) loading. We did not detect colocalization with the plasma membrane marker CD46, confirming
the intracellular location of the loaded C3(H2O) (Supplemental
Figure 3). Additionally, we performed flow cytometry with a goat
pAb to C3 on freshly isolated CD4+ T cells and detected intracellular C3(H2O), but minimal C3, on the plasma membrane (Figure
3B). These data further establish that cell lines can rapidly “load”
C3(H2O) from an exogenous source into the cell interior and, as
the C3(H2O) is transferred into the cell, it migrates in early endosomes. In addition, the detection of C3(H2O) in primary human
cells, but not cultured human cell lines, indicates that in vivo cells
continually take up, store, and process C3(H2O) derived from plasma and/or the interstitial milieu.
α2MR-independent uptake of C3(H2O). Since α2MR-mediated
uptake of C3(H2O) by human fibroblasts has been previously
reported (15), we evaluated its expression on the cell lines used in
this study. Consistent with the literature, fibroblasts expressed the
α2MR, while HUVECs did not (Figure 4A) (20). The ARPE-19 cell
line expressed the α2MR at low levels (Figure 4A). Although Farage cells did not express the α2MR, they rapidly took up C3(MA),
indicating that uptake is not mediated exclusively through this
receptor. To characterize α2MR-mediated uptake on fibroblasts,
the receptor was blocked with increasing concentrations of a mAb
prior to adding C3(H2O) to the culture media. Even on α2MR-

expressing fibroblasts and at all mAb concentrations used, we
detected only a modest decrease (~15%) in C3(H2O) uptake (Figure 4B). Taken together, these data strongly support an α2MRindependent mechanism of uptake.
We next sought to identify the receptor that mediates uptake.
We considered several other candidate receptors and regulatory proteins, including complement receptors that bind C3b and
C3(H2O). To competitively inhibit binding, we employed a strategy in which we separately preincubated cells with a mAb to each
protein prior to loading with C3(H2O). We evaluated uptake in
cell lysates by WB. Specifically, we utilized mAbs to inhibit binding by CD46 (also known as membrane cofactor protein [MCP]),
complement receptor 1 (CR1), complement receptor 2 (CR2), and
complement receptor 3 (CR3) (Supplemental Figure 4, B and C).
In addition to known C3b-binding proteins, we blocked sortilin,
which shares common ligands with the LDLR gene family (i.e., the
α2MR) (Supplemental Figure 4D). In each case, uptake occurred
comparably to that in controls. Thus, the above candidate proteins
are not responsible for C3(H2O) loading.
C3(H2O) recycles to the cell exterior. Because we noticed decreasing quantities of C3(H2O) in PBCs, apparently depending on the
length of time removed from a C3 source, we were interested in
assessing how long such loaded C3(H2O) stores were maintained
intracellularly. To establish C3(H2O)-loading parameters, we first
investigated the magnitude of uptake. After a 1-hour incubation,
Farage cells were saturated with approximately 15 ng of C3(H2O)
per 105 cells (Figure 5A). Next, we investigated the time course of
C3(H2O) uptake. Farage cells loaded C3(H2O) rapidly, with C3(H2O)
detected in cell lysates after being exposed to C3(MA) for even 1
minute (Figure 5B). To investigate the kinetics of loss, Farage cells
(Figure 5C) and Jurkat cells (Figure 5E) were loaded with C3(H2O),
washed, and plated onto FBS-containing culture media for the indicated time points. At each time point, the supernatants were collected, and cell lysates were prepared and then analyzed by WB with a
rabbit anti-C3a pAb. Although the kinetics varied by cell type, Farage (Figure 5C), Jurkat (Figure 5D), and ARPE-19 (Figure 5E) cells
all demonstrated rapid depletion of the internalized C3(H2O) stores.
We next assessed whether the C3(H2O) loss was due to degradation, release, or a combination thereof. The supernatants from
jci.org   Volume 127   Number 3   March 2017
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Figure 4. α2MR-independent uptake of C3. (A) Analysis of α2MR expression on the indicated cell lines by flow cytometry. Gray-filled histogram,
isotype control; red histogram, anti-α2MR. Results are representative of 2
independent experiments. (B) The α2MR was blocked on fibroblasts with
the indicated concentrations of anti-α2MR mAb (μg/ml) prior to incubation with 10% NHS (lanes 5–8). C3, 10 ng (lane 1); 2.4 × 105 cell equivalents
(lanes 2–8). Results are representative of 3 independent experiments.

the Farage cells described above were evaluated via WB. Interestingly, an increase in C3 in the supernatant of Farage cells previously loaded with C3 roughly corresponded to the loss of C3 in the
cell lysates (compare Figure 5F and Figure 5C). Supernatants from
Farage cells not loaded with C3 contained much smaller amounts
of C3 that were minimally, if at all, altered over time (Figure 5F),
therefore establishing that C3 detected in supernatants from
loaded cells was not derived from biosynthesis. Based on our findings that Farage cells internalized approximately 15 ng/105 cells
at saturation (Figure 5A) and secreted approximately 12 ng/ml of
media/105 cells 24 hours after being removed from a C3 source,
we concluded that unstimulated Farage cells secrete approximately 80% of the C3(H2O) and thus may have degraded or metabolized up to approximately 20%.
To determine whether primary cells dissipated C3 stores in
a time frame similar to that of cultured cells, CD4+ T cells were
analyzed by WB for C3 after their removal from peripheral blood.
Due to the time required to isolate CD4+ T cells (~3 hours), C3 loss
at each time point cannot be directly compared with that of Jurkat
cells (Figure 5D). However, in line with what was found with the
latter, CD4+ T cells contained approximately 30% of the detectable C3 by 1 hour and approximately 5% by 24 hours (Figure 5G).
These data indicate that both primary cells and cultured cell lines
lost their C3(H2O) stores fairly rapidly upon removal from a C3
source. This supports the concept that in vivo cells are homeostatically internalizing, processing, and secreting C3(H2O).
974
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C3(H2O) processing by cofactor proteins. Based upon our finding, shown in Figure 5, demonstrating that cells take up C3(H2O),
releasing approximately 80% intact and retaining approximately
20%, we further explored the fate of the internalized/retained
protein. Two possibilities were considered. First, the C3(H2O)
could be inactivated and degraded similarly to the regulation of
C3(H2O) that deposits on a cell membrane. In the latter case, inactivation (i.e., iC3[H2O]) results from cofactor activity (CA) in which
cleavage is mediated by plasma factor I (FI) along with a cofactor
protein (such as CD46 on the cell surface or FH from the plasma).
Consistent with this possibility, we observed cleavage fragments
by WB in Farage cells incubated with purified C3 in the presence of
C3-depleted serum for longer time periods (Supplemental Figure
5). A second possible fate of internalized C3(H2O) would be as a
source for the generation of C3a (similar to our earlier findings,
ref. 4) by an intracellular protease such as CTSL.
To further examine the first possibility, we determined by
WB that Farage cells do not possess endogenous stores of FH or
FI (not shown). Next, we considered the possibility that FH and
FI also might be taken up by cells, especially in light of a recent
finding that apoptotic cells take up FH (7). Thus, we incubated
purified components with cells and washed and performed WBs
on cell lysates. FI was taken up by Farage cells (Figure 6A) by
itself and when incubated with FH. FH also was taken up (Figure 6B). Analysis of subcellular fractions, prepared from Farage
cells incubated with C3(MA), FH, and FI by WB, showed FH in
the membrane and soluble nuclear fractions (Figure 6B). These
are FH-like proteins, FH fragments, or crossreacting bands. Notably, we identified a putative nuclear localization sequence (NLS)
spanning complement control proteins CCP1 and CCP2 in FH
(LRKCQKRPCGH). By FACS analysis, FH was not observed on
the cell membrane (not shown). Thus, we demonstrated FH and
FI in Farage cell lysates after exogenous addition to cell cultures.
Our results indicate that even nonapoptotic cells can take up not
only FH, but also FI.
Next, we loaded Farage cells with C3(H2O) in the presence
of FH and FI and found cleavage products in lysates consistent
with CA. When Farage cells were incubated with C3(MA) alone
or C3(MA) with FI, we detected no fragmentation, but rather the
expected intact C3 α and β chains (Figure 6C), suggesting that
CD46 expressed by Farage did not serve as a cofactor for FImediated cleavage of loaded C3(MA). However, in the presence
of loaded FI and FH, we observed C3(MA) cofactor–mediated
cleavage. That is, incubation of all 3 with Farage cells resulted in
the anticipated breakdown fragments, i.e., the α41 fragment and
the C3a-retaining fragment that migrates at approximately 75 kDa
(Figure 6C). These fragments are identical to purified iC3(H2O)
(Figure 6, C and E). Since the WB employed goat Ab that does not
distinguish the comigrating β chain (75 kDa) from C3a-α1 (72 kDa)
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Figure 5. Characterization of C3(H2O) recycling. (A) The amount of C3(H2O) uptake was assessed by WB and quantified by densitometry. Farage cells
were incubated for 1 hour with increasing concentrations of C3(MA) in 10% C3-depleted serum. Densitometry was used to determine ng of C3(MA) taken
up per 105 cell equivalents. (B) The kinetics of loading were determined by incubating Farage cells with 5 μg/ml C3(MA) for increasing lengths of time and
analyzed by WB. Densitometry was used to assess the amount of C3(H2O) present in the cells at each time point. Inset is a representative WB. (C–E) The
kinetics of C3(H2O) loss from established stores was assessed in Farage (C), Jurkat (D), and ARPE-19 (E) cells. Cells were incubated for 1 hour with 20 μg/ml
C3, washed, and plated in the absence of C3 (normal growth media) for the indicated time points. Densitometric scanning of WB was used to determine
the amount of C3(H2O) remaining in the cells compared with cells lysed immediately after loading. (F) The amount of C3(H2O) released from loaded (C3
loaded) or unloaded (unloaded) Farage cells into the supernatant was assessed by WB at the indicated time points. (G) The kinetics of C3(H2O) loss from
freshly isolated CD4+ T cells that contained C3(H2O) stores loaded in vivo was assessed. The isolated CD4+ T cells were plated in complete media containing
10% FBS and 25 U/ml rhIL-2, and cell lysates were prepared at the indicated time points. Densitometric scanning was used to determine the amount of
C3(H2O) remaining in the cells compared with cells lysed immediately after isolation. (A–G) Data (mean ± SD) are from 2 independent experiments.

(Figure 6C), we also probed the samples with rabbit anti-C3a polyclonal Ab and verified the presence of C3a-α1 (Figure 6C).
The requirement for addition of exogenous FH and FI for CA
suggested that cultured Farage cells do not synthesize or contain
endogenous stores of these proteins that are accessible to the loaded C3(H2O). A time course of C3(H2O) α chain degradation indicated that no cleavage of C3(MA) occurs unless FH and FI are also
loaded (Figure 6D). Further, CA begins quickly (~1 minute) and is
completed by 30 minutes. These studies were also performed with
fibroblasts, and the same results were obtained. These data indicate that cells take up FH and FI and that these proteins then can
mediate intracellular cleavage of the loaded C3(H2O).
C3a is generated from loaded C3(H2O) and is augmented by cell
activation. In addition to degradation by CA, a second fate of
loaded C3(H2O) is to contribute to the generation of C3a. Since

previous reports described the intracellular generation of C3a (4,
11), we examined whether C3a was generated following uptake
from C3(H2O). Intracellular C3a was detected in resting Farage
cells by 15 minutes after exposure to NHS, and its generation
progressively increased over 2 hours (Figure 7A). C3a generation
from loaded C3(H2O) could be detected in multiple cell types (not
shown). Although we could not detect C3a generation by WB in
the absence of uptake, previous studies have detected a scant
amount of C3a via flow cytometry from intracellular stores in cells
not exposed to C3(H2O) (4). This indicates that there are 2 sources
of intracellular C3 stores, i.e., C3a can be generated after uptake
of C3(H2O) from blood or from synthetic C3 stores. In agreement with the latter, we detected C3 mRNA in a survey of cell
lines (Supplemental Figure 6). In addition, C3a generation was
observed following uptake of purified C3(MA), indicating that it
jci.org   Volume 127   Number 3   March 2017
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Figure 6. C3(H2O) processing by
cofactor proteins. Whole cell
lysates (A and B) and subcellular fractions (B) were prepared
from Farage cells incubated
with C3(MA), with or without
FH and FI, and analyzed by WB
with a goat anti-FI pAb (A) or a
goat anti-FH pAb (B). Nonreducing conditions. FH, 20 ng; cell
equivalents, 3 × 105. Representative of 2 independent experiments. (C) Farage cells were
incubated for 15 minutes with 15
μg/ml C3(MA) alone or plus FI (I)
(2 μg/ml), or FI and FH (H) (25
μg/ml). The resulting cell lysates
were analyzed by WB with a goat
anti-C3 pAb (top panel) or a rabbit anti-C3a pAb (bottom panel).
Under reducing conditions. C3,
iC3b and iC3(MA), 20 ng; cell
lysates, 4 × 105 cell equivalents
loaded. Representative of 3
independent experiments. (D)
Lysates prepared from Farage
cells incubated with C3(MA)
alone or with FH and FI for the
times indicated were analyzed
for uptake and CA by WB with a
rabbit anti-C3a pAb. Reducing
conditions. C3, 70 ng; C3a, 30 ng;
cell lysates, 4 × 105 cell equivalents loaded. Representative of
2 independent experiments. (E)
Schematic depicting the cleavage and inactivation of C3(H2O)
resulting from CA. These experiments were also performed with
fibroblasts, and the same results
were obtained.

is due to intracellular cleavage and not a result of other serum factors or convertase activity (not shown). As further evidence for
the conclusion that uptake is not convertase dependent, we show
uptake in the presence of EDTA (Supplemental Figure 7).
To extend this observation and examine biological relevance,
we asked whether C3a generation from loaded C3(H2O) was modulated in activated cells. Farage cells were incubated on anti-IgM–
coated or BSA-coated (nonactivated control) plates for 3 hours in
the presence of 10% NHS. The resulting cell lysates were analyzed
for C3a generation by WB with a rabbit pAb to C3a. Compared
with nonactivated controls, C3a generation significantly increased
in activated Farage cells (Figure 7B). This points to a potentially
important role for C3(H2O) uptake and subsequent C3a generation in B cell activation and function.
To determine whether this phenomenon is of broader significance, we investigated C3a generation by activated CD4+ T cells.
CD4+ T cells were incubated for 3 hours on anti-CD3/CD46–
coated or MOPC-31–coated (nonactivated control) plates in the
presence of 10% NHS. C3a generation was evaluated by WB with
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a rabbit pAb to C3a. As with the Farage cell line, C3a generation
significantly increased in activated CD4+ T cells compared with
nonactivated controls (Figure 7C), and in the absence of NHS,
C3a generation was not detectable by WB (not shown). Therefore,
the observed increase in C3a generated under activating conditions was from loaded C3(H2O). A CTSL-dependent mechanism
for generation of C3a from intracellular C3 stores in CD4+ T cells
has been previously described (4), representing one mechanism
for generation of C3a from loaded C3(H2O). In support of this,
we have demonstrated generation of C3a from C3(MA) by CTSL
in vitro (Supplemental Figure 8A). Additionally, we showed more
efficient cleavage of C3(MA) compared with native C3 by CTSL in
vitro (Supplemental Figure 8B). Since the protease responsible for
C3a generation from C3(H2O) is likely cell type specific, we also
demonstrated cleavage of C3(H2O) by elastase (Supplemental Figure 8C) and granzyme B (Supplemental Figure 8D).
C3(H2O) uptake modulates CD4+ T cell cytokine production.
Previous work has demonstrated that shuttling of intracellulargenerated C3a (with the C3aR) to the cell surface results in a pro-
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Figure 7. Intracellular C3a generation from loaded C3(H2O) is augmented
following cell activation. (A) Cell lysates from Farage cells incubated in
10% NHS for the indicated time points were analyzed for C3a generation by
WB. To determine whether cell activation modulates C3a production, Farage cells (B) were incubated on anti-IgM– or BSA-coated plates or CD4+ T
cells (C) were incubated on anti-CD3/CD46– or MOPC-31–coated plates for 3
hours in the presence of 10% NHS. The resulting cell lysates were assessed
for C3a production by WB. Densitometric scanning of C3a production is
expressed as mean ± SD in bottom panels. n = 3–4 from at least 2 independent experiments. *P < 0.05, 2-tailed Student’s t test. (A–C) Reducing
conditions. C3a, 30 ng; cell lysates, 2 × 105 cell equivalents loaded.

inflammatory phenotype (IFN-γ production) by CD4+ T cells (4).
Since we detected C3a generation from loaded C3(H2O) that was
increased following CD4+ T cell stimulation (Figure 7C), we investigated the effect of C3(H2O) uptake on Th1/Th2 cytokine production by stimulated CD4+ T cells. We costimulated CD4+ T cells
via the T cell receptor (mAb OKT-3) and CD46 (mAb TRA-2-10)
in the presence/absence of C3(H2O) and assessed production of 4
cytokines involved in the Th1 response or contraction. We detected
induction of IL-6 in the presence of C3(H2O) uptake that was significantly augmented by crosslinking the T cell receptor (Figure 8).
This result was specific for C3(H2O), as purified C3b did not augment IL-6 production. These data highlight one example of how
the C3(H2O) recycling pathway contributes to immune defense.
The generation of IL-6, a cytokine with pleiotropic effects, could
influence immune responses as well as regulate metabolic and
regenerative processes (21). Thus, our data suggest the importance
of evaluating the impact of soluble plasma factors when performing in vitro studies assessing cellular immune function.

Discussion

Processing of C3 into the activation fragments C3a and C3b was
traditionally thought to occur predominately if not exclusively in
the extracellular space. A recent report by our group in collaboration with the Kemper laboratory demonstrated intracellular C3
activation from C3 stores in human cells by a convertase-independent process (4). However, in this report, the source of the intracellular C3 stores was not examined. Herein we provide evidence
that one route of establishing these C3 stores is through intracellular loading from blood. We also describe the C3(H2O) uptake
process and its recycling to the extracellular milieu in several cell
types, suggesting that this process is of broad significance.
Our results are consistent with a specific, receptor-mediated
mechanism. This was evident by exclusive uptake of C3(H2O) and

not native C3. These 2 proteins differ primarily but strikingly in
conformation (17–19). Additionally, uptake of labeled C3(H2O) was
competitively reduced/inhibited with unlabeled protein. Further,
we have demonstrated that denatured C3(H2O) was not taken up,
suggesting that recognition of its 3D structure is essential. Also,
mouse C3(H2O) was not loaded into human cell lines, indicating
that this process is species specific. C3(H2O) was located in a plasma membrane–associated pattern within 1 minute of exposure
and then colocalized with early endosomes by 15 minutes after
loading. Finally, uptake was a rapid and saturable process. Our
next goals include identifying the receptor and further elaborating
the intracellular handling and processing of internalized C3(H2O).
To our knowledge, only one previous report has described cellular uptake of C3(H2O) (15). This article suggested that uptake of
C3(H2O) is a means for its clearance — in other words, a straightforward degradation pathway. However, C3(H2O) is not inert. First, it
can combine with factor B (FB) to initiate an alternative pathway
(AP) feedback loop (cleavage of C3 and C5 via C3 and C5 convertases, respectively). Second, it can be proteolytically modified
(both intracellularly and extracellularly) to liberate C3a and probably other C3 α and β chain fragments with biological activity (22).
Here, we demonstrate that this uptake allows for recycling of the
C3(H2O), provides a source of C3a, and affects cell activation phenomena. In agreement with the report by Meilinger et al. (15), we
show that cells specifically internalize C3(H2O) and not native C3.
In contrast with Meilinger et al. (15), we did not find that
uptake is mediated exclusively through the α2MR. We showed
this by 2 methods. First, human cell lines that do not express the
α2MR still loaded C3(H2O). Second, blocking this receptor utilizing α2MR-expressing human fibroblasts did not substantially
abrogate uptake of C3(H2O). Notably, the dominant binding protein identified in the plasma membrane fraction by Meilinger
et al. (15) was an unidentified approximately 80-kDa species, not
the α2MR. This supports our results showing that an unidentified
receptor mediates uptake of C3(H2O) in human cells, either alone
or in conjunction with the α2MR.
Additionally, much of the work by Meilinger et al. (15) was
performed in rodents, whereas we have focused exclusively on
human cells (15). In a single experiment using human fibroblasts,
they demonstrated that receptor-associated protein (RAP), a protein that impairs binding to the α2MR, blocked C3(H2O) uptake.
However, RAP does not exclusively block binding to the α2MR
(23), and other binding partners of RAP are potential candidate
receptors mediating uptake in human fibroblasts. Further, blocking of candidate receptors CD46, CR1, CR2, and CR3 did not
reduce binding. Taken together, these data suggest that C3(H2O)
jci.org   Volume 127   Number 3   March 2017
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Figure 8. C3(H2O) uptake modulates the cytokine profile of activated
CD4+ T cells. Supernatants from CD4+ T cells incubated for 18 hours on
anti-CD3– (mAb OKT-3), anti-CD46– (mAb TRA-2-10), anti-CD3 plus antiCD46–, or nonactivated-coated (NA) (MOPC-31) plates in the presence of
C3(H2O), C3b, or media only were assessed for IL-6, IFN-γ, TNF, and IL-10
by CBA. Experiments with C3b were only performed with NA and α-CD3+
α-CD46 activated cells. Data are expressed as mean ± SEM. n = 6 from
2 healthy donors in 2 independent experiments run in triplicate.
***P < 0.001 by 1-way ANOVA with Bonferroni’s multiple comparison test.

has additional receptors on the plasma membrane responsible for
mediating its uptake. Identifying the receptor or receptors will be
a focus of ongoing studies.
While FH uptake by apoptotic cells has recently been reported (7), we discovered that, in addition to C3(H2O), healthy cells
also load FH. Despite synthesis and storage of FH in certain cell
types (24–27), we did not detect stores in the Farage cell line prior to exposure to a source of FH. Interestingly, after subcellular
fractionation of Farage cells loaded with FH, we detected it in the
soluble nuclear fraction. We also identified a putative NLS spanning the first and second repeats of FH. This result is in line with a
recent report demonstrating FH binding to nucleosomes of apoptotic cells (7). Whether this predicted NLS mediates FH nuclear
targeting and additional roles of FH in the nucleus are interesting
areas for investigation. Notably, another member of the RCAcontaining protein family, CD46, also contains a NLS in its cytoplasmic tail and targets to the nucleus (11, 28).
In addition to demonstrating FH uptake by normal cells and
cell lines, we discovered that the same cell populations load FI.
This plasma serine protease is required for FH or CD46 to mediate CA. In line with this finding and following internalization, FH
and FI function inside the cell in processing of loaded C3(H2O).
Thus, FH and FI cleaved the C3(H2O) α chain to produce iC3(H2O)
(see Figure 6, A and E). It has been reported that C3a can be liberated from C3(H2O) by both trypsin and the C3 convertase (22).
Although this cleavage mediated by a C3 convertase was less
efficient than from the native C3, we show that CTSL, a physiologically relevant intracellular protease, cleaves C3(H2O) more
efficiently that native C3 (Supplemental Figure 8B). Intracellularly, we hypothesize that C3a production could occur from both
C3(H2O) and iC3(H2O). We speculate that C3a may be liberated
more efficiently from iC3(H2O) compared with C3(H2O), providing one possible role for FH and FI loading. This role of loaded FH
is supported by the results of Martin et al., who demonstrated that
apoptotic cell–loaded FH enhanced CTSL-mediated endogenous
C3 cleavage (2016, ref. 7). These data point to a process whereby
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C3(H2O), FH, and FI are internalized and produce iC3(H2O). Subsequently, C3a and other fragments can be released from iC3(H2O)
by intracellular proteases and become available for immune modulation and effector functions (see Supplemental Figure 9). Further clarifying the intracellular processing of C3(H2O) is a current
area of investigation in our laboratory.
To our surprise, a large fraction of the C3(H2O) taken up by
multiple cell types was returned to the media. It did not appear to
be modified, as the Mr was identical to that of C3(H2O) and C3a
and the β chain remained attached. These data are therefore consistent with a C3-recycling pathway involving C3(H2O). This saturable pathway likely operates continuously in vivo (see Supplemental Figure 9). We believe this is a novel pathway of C3 metabolism
that operates in many (if not most) cell types, as we demonstrated
in PBCs and a variety of cultured cell lines. Our hypothesis is that
cells take advantage of this source to trigger not only intracellular
but also interstitial recognition events that lead to cell activation
phenomena and result in enhanced proinflammatory and survival
phenotypes. There are several biological advantages for such a system. First, this represents a source of C3a that is required for Th1
differentiation in CD4+ T cells (4, 29). Second, although C3(H2O)
lacks a reactive thioester and therefore cannot covalently attach
to a pathogen, it can serve as the nidus to initiate the AP feedback
loop to generate a C3 convertase. Such a process could enhance
the recent observation that pathogens opsonized with C3 extracellularly and then gain entrance into the cell interior, where they can
activate an inflammasome pathway (6). These previous studies
were performed in the absence of a source of human complement
and therefore did not take into account C3(H2O) loading. Indeed,
we speculate that in the presence of a source of C3(H2O), cells that
are challenged with an intracellular pathogen will respond more
rapidly and vigorously.
Herein, we report that C3a production occurs from C3(H2O)
following uptake. Additionally, we show that C3a production from
loaded C3(H2O) is increased under activating conditions in both
human CD4+ T cells and the human B cell line Farage, supporting
the concept that this uptake process plays an important role in cellular responses. The significance of intracellular C3a generation is
underscored by previous work from our group showing that CD4+
T cells from autoimmune arthritis patients had an increased generation of C3a (as compared with healthy controls) due to an overactive ICS and that this correlated with an increased Th1 response
(4). Importantly, our results establish that C3(H2O) uptake by
CD4+ T cells alters the induced cytokine profile. Specifically, we
demonstrate IL-6 production that is significantly (Figure 8, P <
0.01) augmented by CD3 crosslinking in the presence of C3(H2O).
Our results, combined with previous work establishing the impor-
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tance of intracellular C3a in immune defense and homeostasis,
point to an essential role for C3(H2O) uptake and processing in
the immune response. Further, generation of IL-6 could affect
processes ranging from inflammation to metabolic reprogramming (21). Highlighting the importance of IL-6 in regulation of
the immune response, the dysregulated production of IL-6 plays
a pathological role in several autoimmune diseases. Further, a
humanized IL-6 receptor Ab, tocilizumab, is therapeutically beneficial in several inflammatory diseases, including rheumatoid
arthritis and Castleman’s disease (reviewed in ref. 30). It has been
previously suggested from studies in Il6 –/– and C3 –/– mice that IL-6
and C3 are linked in regulation of germinal center development
and Ab production (31), and our current results provide additional
mechanistic insight into this process. In view of the multiple possible effects of the induced IL-6, a more in-depth investigation is
underway to explore this phenomenon.
Currently, most in vitro cell activation studies reported in the
literature have been performed in traditional media containing
10% FCS, and therefore, no human C3(H2O) was available for
uptake and intracellular processing. Additionally, other plasma
components may be required to maintain cellular homeostasis or
participate in cell activation phenomena. A role for soluble plasma
factors should be considered when performing in vitro studies
assessing cellular activation phenomena on cells isolated from
blood prior to study.
Although we have shown that C3(H2O) uptake and processing
occurs in many cell types, it is clear that an additional source of C3
is present within human cells. This is evident by the fact that intracellular C3 stores have been identified in C3-deficient individuals
(4, 32–35) as well as in cell lines that have been long removed from
a C3 source (4). One potential source, of course, is biosynthesis and
storage of C3. In agreement with this, we demonstrated C3 mRNA
in the cell lines examined (Supplemental Figure 6). Although most
C3 is secreted, it has been shown that some cell types store C3,
such as human neutrophils (36) and monocytes (37). The derivation and composition of these C3 stores have not been delineated.
Whether these stores have overlapping or distinct roles from those
established by C3(H2O) loading requires further investigation.
In retrospect, as we sought to understand the biologic function of C3(H2O) uptake, we considered the simple concept that
C3(H2O) could be the original gateway to activation of the complement system in cells, on membranes and in the interstitium. In this
scenario, a putative key innate immune role for C3(H2O) uptake
into intracellular C3 stores is to assist in a rapid response of the
host to danger. Thus, the C3 species within the cell and in the interstitium is readily available to generate C3a and other fragments to
initiate substantial and rapid local complement activation at a site
of injury or pathogen invasion. Indeed, such a mechanism could
have been one of the earliest and quickest innate immune defenses developed, an adaptive remnant retained in modern times.
Finally, our data and other recent investigations now broaden the role of the newly discovered ICS (4, 11). The finding of a
C3(H2O)-recycling pathway has important implications for our
understanding of basic processes the cell utilizes for homeostasis
and defense. These data may also suggest potential new therapeutic targets and strategies. We are just beginning to unravel this
complex, intriguing, and important new system.

Methods

Cell lines, Abs, and proteins. The Farage human B cell lymphoma and
Jurkat human T cell leukemia cell lines (ATCC) were grown in RPMI
1640 with 10% heat-inactivated FBS, 100 units/ml penicillin, and 100
μg/ml streptomycin. The ARPE-19 retinal epithelial cell line (ATCC)
was grown in DMEM:F12 with 10% heat-inactivated FBS, 100 units/
ml penicillin, and 100 μg/ml streptomycin. Primary dermal fibroblasts
(ATCC) were grown in basal medium supplemented with the Fibroblast Growth Kit–Low serum (ATCC). Human HUVECs (ATCC) were
grown in vascular cell basal medium supplemented with the Endothelial Cell Growth Kit (ATCC). All cell lines were maintained at 37°C
in 5% CO2. Rabbit anti-human C3a (A218) and goat anti-human C3
(A213) pAbs were obtained from Complement Technologies. Chicken
anti-human C3 (GW20073F) pAb was from Sigma-Aldrich.
Purified human C3 was generated in house (38) or purchased
from Complement Technologies (A113). Purified human C3b (A114),
C3a (A118), FH (A137) and FI (A138), and C3-dpl serum (A314) were
purchased from Complement Technologies. The anti-α2MR mAb
(MA-8G1) used for flow cytometry and blocking experiments was purchased from Molecular Innovations. Ab for B lymphocyte activation
(goat F[ab′]2 anti-human IgM, 2022-01) was purchased from SouthernBiotech. Abs for CD4+ T cell stimulation were generated in house
(anti-CD3, OKT-3 or anti-CD46, TRA-2-10) (39).
Isolation and activation of human lymphocytes. Primary human
lymphocytes were isolated from whole blood samples. B lymphocytes
were isolated from PBCs using MACS B Cell Isolation Kit II (Miltenyi
Biotec). CD4+ T cells were isolated with the EasySep Human CD4+ T
cell Isolation Kit (StemCell Technologies). CD4+ T cells (1 to 1.5 × 105
cells/well) were activated for 3 hours in the presence of 10% NHS or
10% FBS on 96-well culture plates coated with Abs to CD3 and CD46
(2 μg/ml). Cytokine production by activated CD4+ T cells was assessed
by the BD Cytometric Bead Array (CBA) Human Th1/Th2 Cytokine
Kit II. Farage B cells (1 to 1.5 × 105 cells/well) were activated for 3 hours
in the presence of 10% NHS or 10% FBS on 96-well culture plates
coated with anti-IgM (10 μg/ml).
Cell lysate preparation. Cell lysates were prepared by resuspending
cell pellets in cell lysis buffer (1% NP-40, 0.05% SDS, in PBS) with 2 mM
PMSF and ProteaseArrest (G-Biosciences) and incubating for 20 minutes on ice. The resulting lysates were then centrifuged for 10 minutes
at 11,200 g and supernatants collected, aliquoted, and stored at –80°C.
Methylamine and denaturing treatments. C3 was treated with
methylamine to hydrolyze the thioester bond and termed C3(MA) (16,
40). Briefly, purified C3 was incubated with 0.4 M methylamine hydrochloride (Sigma Aldrich) and 0.1 M Tris pH 8.0 for 1 hour at 37°C. To
denature C3(MA), an aliquot was heated at 85°C for 2 minutes.
C3 loading and loss. For C3 loading, 2 × 106 cells/ml were resuspended in serum-free medium containing 20 μg/ml C3(MA) (unless
otherwise indicated). Cells were routinely incubated for 15 minutes
at 37°C. Following incubation, cells were washed 3× with PBS. For C3
loss experiments, after loading, washed cells were plated in 48-well
culture plates at 2 × 106 cells/ml in normal growth media containing
10% FBS and incubated for indicated times before the supernatants
were collected, cell pellets washed, and cell lysates prepared. The
C3 content of the cell lysates and supernatants was analyzed by WB.
Briefly, samples were electrophoresed in reduced or nonreduced
4%–20% SDS-PAGE buffer (unless indicated otherwise), transferred
to nitrocellulose, and probed with rabbit anti-human C3a (A218) or
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goat anti-C3 (A213) pAbs (Complement Technologies), followed by
appropriate HRP-conjugated secondary Abs. Blots were visualized on
a ChemiDoc XRS Imager (Bio-Rad).
FH and FI loading. Similarly to what occurred in the C3 studies,
25 μg/ml FH and/or 4 μg/ml FI were added to the medium of cells
plated at 2 × 106 cells/ml. After 15 minutes at 37°C incubation and
washing (3×) with PBS, the FH and FI concentrations in cell lysates
were analyzed by WB with a goat anti-FH (A237) pAb or a goat anti-FI
(A238) pAb (Complement Technologies).
Enzymatic reactions. Recombinant CTSL (R&D Systems) was activated according to the manufacturer’s instructions. In vitro cleavage of
C3(MA) and C3 by CTSL was performed by incubating 500 ng C3(MA)
or C3 with 2 ng or 300 ng CTSL for 1 hour at 37°C. In vitro cleavage by
elastase (EPC Elastin Products Inc.) was performed by incubating 1 μg
C3(MA) with increasing concentrations of elastase (0–1.3 μg/ml) for
1 hour at 37°C. In vitro cleavage by granzyme B (Enzo Life Sciences)
was performed by incubating 50 ng C3(MA) with 50 ng/ml granzyme
B for 1 hour at 37°C. Cleavage fragments were visualized by WB.
Confocal microscopy and colocalization analysis. Confocal microscopy was performed as previously described (4). Briefly, fixed and
permeabilized cells were stained with primary Abs for 30 minutes at
room temperature (RT). Staining with secondary Abs was performed
by incubation for 30 minutes at RT. Cells were mounted with ProLong
Gold (Thermo Fisher) and incubated at 4°C overnight. For studies
using fluorescent dye–conjugated C3, the C3 was labeled with Dylight
488 using the Dylight 488 Antibody Labeling Kit (Thermo Fisher).
This labeling kit reacts with exposed N-terminal α amino groups or
the ε amino groups of lysine residues to form stable amide bonds.
Following labeling, the C3 is of the form C3(H2O) (see Supplemental
Figure 1B). For colocalization studies, the Cellular Localization IF Ab
Sampler Kit (catalog 4753, Cell Signaling) was employed. Images were
obtained in the Imaging Facility, Department of Molecular Microbiology, WUSM, by confocal fluorescence microscopy. Samples were
visualized with a Zeiss LSM880 with Airyscan laser scanning confocal
microscope (Carl Zeiss Inc.) equipped with a 63×, 1.4 numerical aperture Zeiss Plan Apochromat oil objective.
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